All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @braedenbrah on TikTok · 42s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @braedenbrah's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I'm a little confused on the hype that MK-677 gets.
  2. 0:03It's the fucking worst thing that you can ever take, man.
  3. 0:06Unless you're literally 70 pounds, 5 foot 8.
  4. 0:09Skin and bones. You should not be taking fucking MK-677.
  5. 0:13And that shit is gonna make you fat, ha-
  6. 0:16Have diabetes.
  7. 0:17And you're not gonna look aesthetically a pleasing, bro.
  8. 0:19If I were you, if you're trying to get in a peptide game, like,
  9. 0:22just take a sucker.
  10. 0:22Or a man like...
  11. 0:24Or like, just take rad or fucking inject testosterone, man.
  12. 0:27Stay away from MK, that.
  13. 0:29Honestly, it's the fucking worst thing that you can do for yourself.
  14. 0:32I was planning on hopping on MK. I did a bunch of research.
  15. 0:34That shit is actually awful.
  16. 0:36You have to fucking mentally ill if you want to take MK-677.
  17. 0:40End video.

@braedenbrah's peptide claims need a reality check

braeden.brah

TikTok creator

260.0K viewsWatch on TikTok

Quick answer

MK-677 (ibutamoren) is an oral ghrelin mimetic that increases GH and IGF-1 secretion, with clinical trials documenting reliable but sometimes modest improvements in lean mass alongside consistent impairment of insulin sensitivity and elevated fasting glucose in certain populations. The creator's concern about metabolic side effects is grounded in real pharmacology, but his framing ignores that most human studies were conducted in elderly or deficient populations rather than healthy adults. His suggestion to substitute RAD-140 or self-administered testosterone as safer alternatives is not supported by the evidence and introduces serious unaddressed risks.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @braedenbrah's peptide claims need a reality check, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@braedenbrah's peptide claims need a reality check is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@braedenbrah's peptide claims need a reality check" from braeden.brah. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 (ibutamoren) is an oral ghrelin mimetic that increases GH and IGF-1 secretion, with clinical trials documenting reliable but sometimes modest improvements in lean mass alongside consistent impairment of insulin sensitivity and elevated fasting glucose in certain populations.

The reason this review is not generic is the source wording and the canonical claim label "peptides what the yap gym 2010 gymbro gymtok." In this clip, the useful excerpt is: "I'm a little confused on the hype that MK-677 gets." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

MK-677 is not an FDA-approved drug or supplement.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

MK-677 (ibutamoren) is an oral ghrelin mimetic that increases GH and IGF-1 secretion, with clinical trials documenting reliable but sometimes modest improvements in lean mass alongside consistent impairment of insulin sensitivity and elevated fasting glucose in certain populations.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • MK-677 (ibutamoren) is an oral ghrelin mimetic that increases GH and IGF-1 secretion, with clinical trials documenting reliable but sometimes modest improvements in lean mass alongside consistent impairment of insulin sensitivity and elevated fasting glucose in certain populations. The creator's concern about metabolic side effects is grounded in real pharmacology, but his framing ignores that most human studies were conducted in elderly or deficient populations rather than healthy adults. His suggestion to substitute RAD-140 or self-administered testosterone as safer alternatives is not supported by the evidence and introduces serious unaddressed risks.
  • Nass et al. (2008, JCEM) confirmed MK-677 raises IGF-1 meaningfully in older adults but also documented worsened fasting glucose and insulin resistance in a subset of participants.
  • MK-677 is not an FDA-approved drug or supplement. It remains an investigational compound with no approved indication for healthy adults.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Nass et al. (2008, JCEM) confirmed MK-677 raises IGF-1 meaningfully in older adults but also documented worsened fasting glucose and insulin resistance in a subset of participants.
  • MK-677 is not an FDA-approved drug or supplement. It remains an investigational compound with no approved indication for healthy adults.
  • The appetite increase from MK-677 is a direct pharmacological effect of ghrelin receptor agonism, not a user error. It is real and consistent across studies.
  • RAD-140, suggested as a safer swap, was linked to severe drug-induced liver injury in a 2020 ACG Case Reports case documented by Flores et al.
  • Insulin sensitivity impairment from MK-677 is dose-related and reversible upon discontinuation based on available clinical data, which the creator did not mention.
  • Most human MK-677 research was conducted in elderly, GH-deficient, or muscle-wasting populations. Extrapolating those findings to healthy gym users in either direction requires caution.
  • Anyone considering a growth hormone secretagogue should have fasting glucose and insulin levels assessed at baseline by a licensed clinician before starting.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @braedenbrah actually say?

The creator came in hot with a simple message: MK-677 is "the fucking worst thing that you can ever take" unless you're severely underweight. He claimed it will make you fat, give you diabetes, and ruin your physique. He also suggested people just take SARMs like RAD-140 or inject testosterone instead. The whole take landed somewhere between legitimate concern and gym-bro overconfidence.

To be fair, some of what he said points at real pharmacological issues. MK-677 does mess with insulin sensitivity and does cause water retention and increased appetite. Those aren't myths. But the delivery, the blanket condemnation, and the breezy pivot to "just inject testosterone" undercut the credibility here significantly.

Does the science back this up?

Partially. MK-677 is a ghrelin mimetic that stimulates growth hormone secretion orally. The concern about blood sugar is real and documented. The claim that it makes everyone fat is an oversimplification.

A 2008 study by Nass et al. in the Journal of Clinical Endocrinology and Metabolism found that MK-677 increased GH and IGF-1 levels in older adults but also worsened fasting glucose and insulin sensitivity in a subset of participants. A 1998 clinical trial by Murphy et al. in the same journal confirmed similar metabolic trade-offs. So yes, there is a documented insulin resistance signal. However, context matters. These studies used specific populations, and the outcomes were not universal. The appetite stimulation is also real. MK-677 reliably increases hunger, which in someone eating at a surplus already can absolutely contribute to fat gain. That part of his claim holds up. What doesn't hold up is the absolutism.

What did they get wrong (or right)?

He got the metabolic risk directionally right but wildly overstated it. He got the recommendation catastrophically wrong.

The pivot to "just take RAD" or "inject testosterone" as safer alternatives is, frankly, irresponsible. RAD-140 is an unapproved investigational SARM with no long-term human safety data and documented cases of drug-induced liver injury. A 2020 case report by Flores et al. in ACG Case Reports described severe hepatotoxicity linked to RAD-140 use. Testosterone injection carries its own suppression, cardiovascular, and hematological risks that are not trivial for someone self-administering without medical oversight.

The idea that MK-677 is uniquely dangerous compared to these options doesn't hold up to scrutiny. He's essentially saying "don't take the drug that raises blood sugar, take the drug with liver toxicity risk instead." That's not a safety upgrade. The one thing he genuinely got right is that MK-677 is not a benign supplement and deserves more skepticism than gym culture gives it.

What should you actually know?

MK-677 is not approved by the FDA for any indication. It is not a peptide in the strict biochemical sense. It is a small-molecule ghrelin receptor agonist. That distinction matters because it behaves differently from injectable growth hormone secretagogues like ipamorelin or CJC-1295.

The legitimate clinical research on MK-677 has focused on specific populations: elderly patients with GH deficiency, people with hip fractures, and individuals with muscle-wasting conditions. Nass et al. 2008 and Svensson et al. 1998 (JCEM) both found benefits in those contexts alongside metabolic downsides. Applying those findings to healthy, recreationally active adults is a stretch the data doesn't support either way.

If you're considering any growth hormone secretagogue, the conversation belongs with a licensed clinician who can assess your metabolic baseline, not a TikTok comment section. The blood sugar concern is real enough to warrant actual lab work, not just a vibe check.

  • MK-677 raises GH and IGF-1 but consistently impairs insulin sensitivity in clinical studies
  • Increased appetite is a pharmacological effect, not a side effect you can will away
  • RAD-140 and self-administered testosterone carry serious, documented risks that were not mentioned
  • No peptide or secretagogue should be used to address or treat any diagnosed medical condition without physician oversight

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

braeden.brah · TikTok creator

260.0K views on this video

what the yap #gym #2010 #gymbro #gymtok

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about nass et al. (2008, jcem) confirmed mk-677 raises igf-1 meaningfully?

Nass et al. (2008, JCEM) confirmed MK-677 raises IGF-1 meaningfully in older adults but also documented worsened fasting glucose and insulin resistance in a subset of participants.

What does the video say about mk-677?

MK-677 is not an FDA-approved drug or supplement. It remains an investigational compound with no approved indication for healthy adults.

What does the video say about the appetite increase from mk-677?

The appetite increase from MK-677 is a direct pharmacological effect of ghrelin receptor agonism, not a user error. It is real and consistent across studies.

What does the video say about rad-140, suggested as a safer swap, was linked to severe?

RAD-140, suggested as a safer swap, was linked to severe drug-induced liver injury in a 2020 ACG Case Reports case documented by Flores et al.

What does the video say about insulin sensitivity impairment from mk-677?

Insulin sensitivity impairment from MK-677 is dose-related and reversible upon discontinuation based on available clinical data, which the creator did not mention.

What does the video say about most human mk-677 research was conducted in elderly, gh-deficient,?

Most human MK-677 research was conducted in elderly, GH-deficient, or muscle-wasting populations. Extrapolating those findings to healthy gym users in either direction requires caution.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by braeden.brah, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.